Hung Do

US·SEC (Form 4)

Amicus Therapeutics, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (18 ops.)

€9.5M

Latest filing published 08 Apr 2021 for Amicus Therapeutics, INC..

Filing timeline

BuySale

Hung Do

Insider track record

Disclosed buys

Disclosed sells

Signal history

Hung Do: trading record in brief

Hung Do appears in our data through filings on Amicus Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 65 filings, for trades running from 7 March 2014 to 6 April 2021.

Every open-market trade on record is a sale: 18 sales worth €9.5M. The rest of the record consists of 24 share grants and 11 option exercises.

The newest entry dates from 8 April 2021: a share grant, in Amicus Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Hung Do

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Amicus Therapeutics, Inc. (US)

Declarations64 total

◆
Hung Do
Chief Science OfficerExecutives6 Apr 2021Amicus Therapeutics, Inc.
0SEC
20,501 shares0Common StockSEC:0001209191-21-026164:0
◆
Hung Do
Chief Science OfficerExecutives15 Jan 2021Amicus Therapeutics, Inc.
0SEC
22,458 sharesCommon StockSEC:0001209191-21-004471:0
◆
Hung Do
Chief Science OfficerExecutives15 Jan 2021Amicus Therapeutics, Inc.
217,526 USD11SEC
9,960 shares@ US$21.841.4% of flowCommon StockSEC:0001209191-21-004471:1
◆
Hung Do
Chief Science OfficerExecutives2 Jan 2021Amicus Therapeutics, Inc.
331,526 USD11SEC
14,358 shares@ US$23.092.2% of flowCommon StockSEC:0001209191-21-001665:1
◆
Hung Do
Chief Science OfficerExecutives31 Dec 2020Amicus Therapeutics, Inc.
123,301 USD11SEC
5,340 shares@ US$23.090.8% of flowCommon StockSEC:0001209191-21-001665:0
◆
Hung Do
Chief Science OfficerExecutives4 Jan 2021Amicus Therapeutics, Inc.
0SEC
34,572 sharesCommon StockSEC:0001209191-21-001665:3
◆
Hung Do
Chief Science OfficerExecutives3 Jan 2021Amicus Therapeutics, Inc.
206,378 USD11SEC
8,938 shares@ US$23.091.3% of flowCommon StockSEC:0001209191-21-001665:2
▼
Hung Do
Chief Science OfficerExecutives14 Dec 2020Amicus Therapeutics, Inc.
3M USD29SEC
111,125 shares@ US$23.876528.5% of flowCommon StockSEC:0001209191-20-063839:0
◇
Hung Do
Chief Science OfficerExecutives9 Oct 2020Amicus Therapeutics, Inc.
376,257 USD11SEC
43,700 shares@ US$8.614.2% of flowCommon StockSEC:0001209191-20-054670:0
◇
Hung Do
Chief Science OfficerExecutives9 Oct 2020Amicus Therapeutics, Inc.
921,000 USD12SEC
75,000 shares@ US$12.2810.2% of flowCommon StockSEC:0001209191-20-054670:1
◇
Hung Do
Chief Science OfficerExecutives9 Oct 2020Amicus Therapeutics, Inc.
677,250 USD12SEC
75,000 shares@ US$9.037.5% of flowCommon StockSEC:0001209191-20-054670:2
▼
Hung Do
Chief Science OfficerExecutives9 Oct 2020Amicus Therapeutics, Inc.
3M USD32SEC
193,700 shares@ US$15.029832.2% of flowCommon StockSEC:0001209191-20-054670:3
◆
Hung Do
Chief Science OfficerExecutives15 Jun 2020Amicus Therapeutics, Inc.
16,108 USD11SEC
1,446 shares@ US$11.140.2% of flowCommon StockSEC:0001209191-20-037472:0
◆
Hung Do
Chief Science OfficerExecutives1 Apr 2020Amicus Therapeutics, Inc.
0SEC
11,354 shares0Common StockSEC:0001209191-20-023443:0
◇
Hung Do
Chief Science OfficerExecutives12 Feb 2020Amicus Therapeutics, Inc.
54,243 USD11SEC
6,300 shares@ US$8.610.6% of flowCommon StockSEC:0001209191-20-009645:0
◇
Hung Do
Chief Science OfficerExecutives12 Feb 2020Amicus Therapeutics, Inc.
177,803 USD11SEC
29,148 shares@ US$6.102.1% of flowCommon StockSEC:0001209191-20-009645:1
◇
Hung Do
Chief Science OfficerExecutives12 Feb 2020Amicus Therapeutics, Inc.
90,555 USD11SEC
17,652 shares@ US$5.131.1% of flowCommon StockSEC:0001209191-20-009645:2
▼
Hung Do
Chief Science OfficerExecutives12 Feb 2020Amicus Therapeutics, Inc.
697,550 USD30SEC
63,356 shares@ US$11.018.3% of flowCommon StockSEC:0001209191-20-009645:3
◆
Hung Do
Chief Science OfficerExecutives10 Jan 2020Amicus Therapeutics, Inc.
0SEC
40,828 sharesCommon StockSEC:0001209191-20-003378:0
◆
Hung Do
Chief Science OfficerExecutives10 Jan 2020Amicus Therapeutics, Inc.
178,832 USD11SEC
18,904 shares@ US$9.461.9% of flowCommon StockSEC:0001209191-20-003378:1
◆
Hung Do
Chief Science OfficerExecutives2 Jan 2020Amicus Therapeutics, Inc.
67,490 USD11SEC
7,067 shares@ US$9.550.7% of flowCommon StockSEC:0001209191-20-002149:0
◆
Hung Do
Chief Science OfficerExecutives3 Jan 2020Amicus Therapeutics, Inc.
85,649 USD11SEC
9,330 shares@ US$9.180.9% of flowCommon StockSEC:0001209191-20-002149:1
◆
Hung Do
Chief Science OfficerExecutives2 Jan 2020Amicus Therapeutics, Inc.
0SEC
68,446 sharesCommon StockSEC:0001209191-20-001224:1
◆
Hung Do
Chief Science OfficerExecutives31 Dec 2019Amicus Therapeutics, Inc.
99,533 USD11SEC
10,219 shares@ US$9.741.0% of flowCommon StockSEC:0001209191-20-001224:0
◆
Hung Do
Chief Science OfficerExecutives14 Jun 2019Amicus Therapeutics, Inc.
16,412 USD11SEC
1,446 shares@ US$11.350.1% of flowCommon StockSEC:0001209191-19-037812:0

25 of 64 declarations

Hung Do

Insider track record

Hung Do: trading record in brief

Companies and markets linked to Hung Do

Similar companies

Related executives